PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinomaJiaxin Cao, Hongyun Zhao|Cell Death and Disease|2024Cited by 4